More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
Adobe Class Action
Data Breach and Privacy, Existing Cases
On April 3, 2025, Lowey filed a data privacy class action against Adobe, Inc. alleging it used consumers’ personally identifiable information and online activity to create user profiles without obtaining […]
UCSF Class Action
Data Breach and Privacy, Existing Cases
In Doe v. The Regents of the University of California, No. 3:23-cv-00598 (N.D. Cal.), Lowey Dannenberg represents a class of individuals who used the University of California San Francisco Medical […]
News
Lowey Dannenberg Appointed Co-Lead Counsel in Lumen Technologies, Inc. Stockholder Derivative Litigation
On April 21, 2025, Hon. Kayla D. McClusky, United States Magistrate Judge, appointed Lowey Dannenberg, P.C. as the Co-Lead counsel representing Plaintiffs and a proposed class in the consolidated action: In re Lumen Technologies, Inc. Stockholder Derivative...
Blog
SPAC Update
The special purpose acquisition company (“SPAC”) continues to have a profound impact on stock markets. We have written previously about the increasing popularity of SPAC’s and the risks inherent to SPAC’s. The SPAC device attempts to sidestep the SEC review process by bringing companies public...

